Evaluation of Paclitaxel in Patients With CLI (Critical Limb Ischemia) and Femoropopliteal Occlusive Disease Treated With DCB Angioplasty
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral ischaemia
- Focus Therapeutic Use
- 29 Sep 2016 Planned primary completion date changed from 1 Jun 2020 to 1 Aug 2020.
- 29 Sep 2016 Status changed from not yet recruiting to recruiting.
- 05 Jul 2016 Age criteria for the patients has been changed from 18-85 to 40-95 Years.